TrialInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2023

Open-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein vaccine (FINLAY-FR-1A) in children.

Rinaldo Puga-Gómez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.